Investigators' Site: Anaconda™ Stent Graft System Phase II IDE Clinical Study
Terumo Cardiovascular Systems is sponsoring a Phase II IDE Clinical Study for the Anaconda™ Stent Graft System in the U.S. The Anaconda system is manufactured
by Scotland-based Terumo subsidiary Vascutek Ltd.
The objective of the Anaconda Stent Graft System Phase II IDE Study (G030036) is to assess the safety and effectiveness of the Anaconda Stent Graft System in patients presenting with AAA (Abdominal Aortic Aneurysm) when compared to historical open surgical repair.
Visit www.clinicaltrials.gov for public information about the trial.
Also, see related media releases:
» July 21, 2009